Document text
Principal Investigator: Brent W Segelke
Organization: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC
Fiscal Year: 2022
Award: $350,659
Funding agency: National Institute of Allergy and Infectious Diseases
PROJECT SUMMARY/ABSTRACT
Project Title: Scientific Core 2: Protein Expression and Characterization Core
We will establish and operate a protein expression and characterization core that serves the Cooperative
Research Center for Nano-Scaffold Vaccines Against Chlamydia trachomatis (Ct) by providing facilities,
expertise, effort, materials, and information management to help achieve the aims of the individual projects.
We will establish and maintain facilities with lab space, instrumentation, and storage necessary for production,
characterization, preservation, and distribution of expression plasmids, nanolipoprotein particles, and protein
antigens. We will establish and maintain procedures and training materials sufficient to develop personnel
with the expertise necessary to support the protein production needs of the individual projects. The facility will
be staffed to provide the effort required for protein production and characterization, as requested by
participating projects. We will operate as an on-demand service center, although commonly used, archivable
materials may be produced in bulk, aliquoted, and stored for ready distributions. A regular production
schedule may also be necessary for perishable materials that form the basis of a projects' vaccine technology,
plasmids for cell-free translation within Project 1, and fully formed NLPs for RNA-based vaccines in project 2,
for example. For regularly used materials, we will establish quality metrics and maintain a quality control
program to ensure reproducibility of results from materials we generate. We will work with affiliated projects
to aggregate production and characterization protocols and to determine acceptable tolerances for metrics of
quality control. We will establish an information management system, likely rudimentary to start, such that
materials distributed from the core can be traced back to the procedures, personnel, materials, and associated
metadata, such as quality assessments, associated with the distributed materials across all 3 Projects. The core
will be highly centralized with personnel and facilities at Lawrence Livermore National Laboratory (LLNL), but
some key equipment and expertise may not be available at LLNL, in which case we will partner with outside
facilities. As time and resources permit, the protein production and characterization core will work to diversify
the portfolio of nanolipoprotein particles for vaccine delivery, scale production of NLPs, formulate less
perishable preparations of NLPs, and explore use of single particle methods, such as particle tracking, for
characterization and quality control. The protein production and characterization core can also work as a user
facility, providing training and access to facilities that might enable research and development for individual
project that do not have the expertise or equipment at their locations.
Terms: <Affect><Animal Model><Animal Models and Related Studies><Antigens><Archives><Back><C trachomatis><C. trachomatis><Cell Body><Cell Line><CellLine><Cells><Chlamydia trachomatis><Collection><Development and Research><Dorsum><Encapsulated><Ensure><Equipment><Formulation><Goals><Human><Human Resources><Individual><Information Management><Institution><Investigators><Laboratories><Location><Management Information Systems><Manpower><Metadata><Methods><Modern Man><Nucleic Acid Vaccines><Pathogenesis><Plasmids><Preparation><Procedures><Production><Proteins><Protocol><Protocols documentation><Quality Control><R & D><R&D><RNA vaccine><RNA-based vaccine><Reproducibility><Reproducibility of Findings><Reproducibility of Results><Research><Research Personnel><Research Resources><Researchers><Resources><Rickettsia trachomae><Sampling><Schedule><Services><Strains Cell Lines><System><Techniques><Technology><Testing><Time><Training><Translating><Translations><Vaccines><Work><base><cultured cell line><deliver vaccines><depository><design><designing><develop a vaccine><develop vaccines><development of a vaccine><immunogen><instrumentation><mRNA vaccine><mRNA-based vaccine><member><meta data><model of animal><model organism><nano><nano formulation><nano materials><nanoformulation><nanolipoprotein particles><nanomaterials><novel><nucleic acid-based vaccine><particle><personnel><preservation><programs><protein expression><repository><research and development><scaffold><scaffolding><translational applications><vaccine delivery><vaccine development><vaccine formulation>